Edition:
United Kingdom

OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

126JPY
18 Apr 2019
Change (% chg)

¥-2 (-1.56%)
Prev Close
¥128
Open
¥128
Day's High
¥129
Day's Low
¥126
Volume
746,700
Avg. Vol
1,219,967
52-wk High
¥217
52-wk Low
¥108

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Kyoko Fujiya

53 2019 President, President of Subsidiary, Representative Director

Suyoun Chung

35 2019 Director of Clinical Development, Director

Takuya Tsunoda

54 2014 Director

Hiroshi Yamaji

53 2005 Director

Toyomasa Katagiri

47 2010 Independent Director